XML 38 R29.htm IDEA: XBRL DOCUMENT v3.24.3
PRODUCT REVENUES, NET, ACCOUNTS RECEIVABLE, NET, AND RESERVES FOR PRODUCT REVENUES (Tables)
9 Months Ended
Sep. 30, 2024
Receivables, Net, Current [Abstract]  
Summary of Product Revenues

Net product revenues, which includes revenues associated with the PMO Products and ELEVIDYS, consisted of the following:

 

 

For the Three Months Ended
September 30,

 

 

For the Nine Months Ended
September 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

 

 

(in thousands)

 

PMO Products

 

 

 

 

 

 

 

 

 

 

 

 

United States

 

$

210,683

 

 

$

198,069

 

 

$

604,598

 

 

$

602,415

 

Rest of World

 

 

38,105

 

 

 

42,145

 

 

 

108,565

 

 

 

108,282

 

Total PMO product revenues, net

 

$

248,788

 

 

$

240,214

 

 

$

713,163

 

 

$

710,697

 

ELEVIDYS

 

 

 

 

 

 

 

 

 

 

 

 

United States

 

 

180,983

 

 

 

69,108

 

 

 

436,640

 

 

 

69,108

 

Total ELEVIDYS product revenue, net

 

$

180,983

 

 

$

69,108

 

 

$

436,640

 

 

$

69,108

 

Total product revenues, net

 

$

429,771

 

 

$

309,322

 

 

$

1,149,803

 

 

$

779,805

 

 

Schedule of Product revenue Concentration risks

The following table summarizes the Company's net product revenues, by customer, for those customers that exceeded 10% for the periods indicated:

 

 

For the Three Months Ended
September 30,

 

 

For the Nine Months Ended
September 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Product revenues, net

 

 

 

 

 

 

 

 

 

 

 

 

Customer 1

 

 

28

%

 

 

40

%

 

 

33

%

 

 

45

%

Customer 2

 

 

19

%

 

 

23

%

 

 

20

%

 

 

29

%

Summary of Change in Reserves for Discounts and Allowances

The following tables summarize an analysis of the change in reserves for discounts and allowances for each of the periods indicated:

 

 

Chargebacks

 

 

Rebates

 

 

Prompt Pay

 

 

Other Accruals

 

 

Total

 

 

 

(in thousands)

 

Balance, as of December 31, 2023

 

$

27,486

 

 

$

98,194

 

 

$

3,831

 

 

$

35,261

 

 

$

164,772

 

Provision

 

 

72,832

 

 

 

118,228

 

 

 

13,442

 

 

 

53,674

 

 

 

258,176

 

Adjustments relating to prior periods

 

 

783

 

 

 

(8,716

)

 

 

 

 

 

(88

)

 

 

(8,021

)

Payments/credits

 

 

(77,808

)

 

 

(100,693

)

 

 

(12,191

)

 

 

(58,741

)

 

 

(249,433

)

Balance, as of September 30, 2024

 

$

23,293

 

 

$

107,013

 

 

$

5,082

 

 

$

30,106

 

 

$

165,494

 

 

 

 

 

Chargebacks

 

 

Rebates

 

 

Prompt Pay

 

 

Other Accruals

 

 

Total

 

 

 

(in thousands)

 

Balance, as of December 31, 2022

 

$

417

 

 

$

67,493

 

 

$

3,343

 

 

$

23,445

 

 

$

94,698

 

Provision

 

 

18,191

 

 

 

94,025

 

 

 

11,251

 

 

 

52,500

 

 

 

175,967

 

Adjustments relating to prior periods

 

 

110

 

 

 

(4,154

)

 

 

 

 

 

 

 

 

(4,044

)

Payments/credits

 

 

(9,386

)

 

 

(73,317

)

 

 

(10,586

)

 

 

(40,048

)

 

 

(133,337

)

Balance, as of September 30, 2023

 

$

9,332

 

 

$

84,047

 

 

$

4,008

 

 

$

35,897

 

 

$

133,284

 

Summary of Total Reserves Included in Consolidated Balance Sheets

The following table summarizes the total reserves above included in the Company’s unaudited condensed consolidated balance sheets for each of the periods indicated:

 

 

 

As of
September 30, 2024

 

 

As of
December 31, 2023

 

 

 

(in thousands)

 

Reduction to accounts receivable, net

 

$

56,773

 

 

$

64,697

 

Component of accrued expenses

 

 

108,721

 

 

 

100,075

 

Total reserves

 

$

165,494

 

 

$

164,772